Back to Search
Start Over
Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors
- Source :
- Journal of Thrombosis and Haemostasis; 20230101, Issue: Preprints
- Publication Year :
- 2023
-
Abstract
- Bleeding episodes in hemophiliacs with inhibitors are difficult to control. STSP-0601, a specific factor X (FX) activator purified from the venom of Daboia russelii siamensis, has been developed.
Details
- Language :
- English
- ISSN :
- 15387933 and 15387836
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Journal of Thrombosis and Haemostasis
- Publication Type :
- Periodical
- Accession number :
- ejs62253126
- Full Text :
- https://doi.org/10.1016/j.jtha.2023.01.040